'Lock-and-key' chemistry keeps cancer drugs inactive until they reach tumor sites
Many therapeutic molecules used in cancer treatments are highly toxic, often harming healthy tissues and causing significant side effects. This creates a critical need for strategies that localize their toxic activity to tumors. What if cancer drugs could stay dormant until they reach cancer cells? A new study by Syracuse University researchers demonstrates a promising chemistry-based strategy that could do just that.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
